Form 4: Acelyrin Director Patrick Machado Acquires Stock Options

Director Patrick Machado acquired stock options for 92,158 shares of Acelyrin, Inc. at an exercise price of $4.46 on June 7, 2024.

Summary

• Patrick Machado, a director of Acelyrin, Inc. (SLRN), acquired stock options on June 7, 2024.
• The options grant the right to buy 92,158 shares of Acelyrin's common stock at an exercise price of $4.46 per share.
• The options vest on the earlier of June 7, 2025, or the day before the next annual meeting of stockholders, contingent upon Machado's continued service as a director.
• Following the transaction, Machado directly owns options for 92,158 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants to a director, which is a common practice. It doesn't inherently indicate positive or negative sentiment, but rather reflects standard compensation practices.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence by a company director.

Key Dates